Member Info for Soupdragon78

Not quite deceptive, but I get what you mean.

The tests are quick to do, but the procurement may not be.

Remember in September when they changed to this direction, they were going to undertake them immediately, then 5 months later said they'd only just got the donor tissue needed.

Sorry Mars, you're not correct there. Its duration of drug action for the treatment, how long the drug is effective for.

They need donor lungs as this is tested in lab conditions. Thats the question now, when are the donor lungs available?

Wonder if they have the lung tissue available or will they be waiting for donors again?

Great to get some positive results at last.

‘… near complete ablation of fibrosis’ is a great line.

There's always another tomorrow to look forward to.

It’s the one downside of outlicensing, you can’t control the speed at which the partner progresses.

Not sure they had the money to do much with it Filter. Their funding was going towards their lead asset, which I’m guessing they would then use to fundraise.

Looking like yesterday was a bit of an attempt by the 10%-er's with a few now pondering how to exit.

Filter. The rider was last seen wandering around the paddock whistling the Littlest Hobo theme tune.

Bad horsey... wrong direction.

Go horsey!

At least there is no tomorrow tomorrow.

Which tomorrow?

At least Chab is still sneakily buying 1 share at a time ;-)

If you are half the person you claim to be then you would not be engaging in petty discourse on an anonymous bulletin board of a 2m Mcap company.

Mulderoutthere
Posted in: NFX
Posts: 88
Price: 0.38
No Opinion
RE: Finance10 Jun 2022 13:59

My position on the company is based on 30 years of biotech experience, several billion in deals executed .

Pots and kettles Mulder. You’ve tried to make out that people here are deliberately misleading.

You tried to make out I was some kind of management insider because I had the ability to read public information and make a deduction.

Maybe you should consider an apology first.

Sighs. That’s why Kinaset outlicensed it from Vectura for $40m.

Do try and keep up. Your 30 years and billions of pounds worth of deals you’ve done seem to be taking their toll.

I do enjoy these slip ups.

'Not true - I wanted to know how you knew before it was announced ?'

Mulder never asked me how I knew. Only one poster did, that was Foremagnus.

Mulder also tried to tell us that NFX got a UK innovate grant to investigate tranilast with Vectura and was completely wrong about that.

Deliberately trying to mislead people.

Because he came here using those accounts to tell people NXP004 couldn't be based on Olaparib but was wrong on that and got caught out.